Craig Adam R

CIK 00013394984 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001339498

Recent Transactions

50 trades

Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-10-29+2,329,154→ 2,329,154 total
Purchase
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-10-23$2.90/sh+86,206→ 376,087 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-08-14+289,881→ 289,881 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-08-14+529,201→ 529,201 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-08-12+1,609,873→ 1,609,873 total
Disposition from Tender
CTI BIOPHARMA CORP
Common Stock
2023-06-26$9.10/sh−31,470→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−1,200,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−475,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−1,115,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−470,054→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−2,320,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−800,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−900,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−450,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−600,000→ 0 total
Award
CTI BIOPHARMA CORP
Stock Option (right to buy)
2023-03-14+900,000→ 900,000 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2023-01-24−2,117→ 470,054 total
Sale
CTI BIOPHARMA CORP
common stock
2023-01-24$6.01/sh−2,117→ 29,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2023-01-24$0.84/sh+2,117→ 31,557 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2023-01-24$0.84/sh+83,200→ 112,640 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2023-01-24−83,200→ 472,171 total
Sale
CTI BIOPHARMA CORP
common stock
2023-01-24$6.00/sh−83,200→ 29,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2023-01-03−84,683→ 555,371 total
Sale
CTI BIOPHARMA CORP
common stock
2023-01-03$6.01/sh−84,683→ 29,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2023-01-03$0.84/sh+84,683→ 114,123 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.00/sh−12,000→ 29,440 total
Award
CTI BIOPHARMA CORP
common stock
2022-12-30$5.11/sh+1,579→ 29,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.84/sh+12,000→ 41,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−12,000→ 645,154 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.01/sh−4,400→ 29,440 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−700→ 644,454 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−4,400→ 640,054 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.84/sh+4,400→ 33,840 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.84/sh+700→ 30,140 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.00/sh−700→ 29,440 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-29$6.00/sh−13,800→ 27,861 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-29$0.84/sh+13,800→ 41,661 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-29−13,800→ 657,154 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.04/sh−2,700→ 27,861 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.03/sh−5,800→ 30,561 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.01/sh−100→ 52,757 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.01/sh−26,700→ 52,857 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.00/sh−200→ 79,557 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.00/sh−136,408→ 79,757 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-11-10$0.84/sh+188,304→ 216,165 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-10$6.02/sh−16,396→ 36,361 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-11-10−188,304→ 670,954 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-11-09−53,996→ 859,258 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-09$6.01/sh−7,596→ 28,161 total
Sale
CTI BIOPHARMA CORP
common stock
2022-11-09$6.00/sh−46,100→ 35,757 total

Companies

Recent Filings

Address

C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER PT. BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov